Pharmaceutical composition for ultrasonic interventional therapy of pelvic abscess and preparation method of pharmaceutical composition
A technology for interventional treatment and pelvic abscess, which is applied in the directions of drug combination, drug formulation, drug delivery, etc., can solve the problem that the effect of antibiotic treatment is not completely satisfactory, and achieve the effect of improving drug efficacy, high safety, and enhancing immunity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0018] The pharmaceutical composition for ultrasonic interventional treatment of pelvic abscess is mainly composed of the following components by weight: 3 parts of artificial bezoar, 2 parts of acetylsalicylic acid, 1 part of solanine, 0.01 part of metronidazole, blood root 0.2 parts of alkali, 0.5 parts of chelerythrine, 0.8 parts of forsythol, 0.3 parts of hyperoside, 0.2 parts of isorhamnetin, 0.5 parts of houttuyniatin, 0.6 parts of terpene, 0.1 part of kaempferol , 0.1 part of resveratrol.
[0019] The preparation method of the pharmaceutical composition for ultrasonic interventional treatment of pelvic abscess is as follows:
[0020] (1) Take artificial bezoar, acetylsalicylic acid, solanine, metronidazole, sanguinarine, chelerythrine, forsythol, hyperin, isorhamnetin of said weight portion , houttuyniatin, untethered terpene, kaempferol, resveratrol, spare;
[0021] (2) the acetylsalicylic acid, metronidazole, sanguinarine, chelerythrine, forsythol, hyperoside, houtt...
Embodiment 2
[0025] The pharmaceutical composition for ultrasonic interventional treatment of pelvic abscess is mainly composed of the following components by weight: 4 parts of artificial bezoar, 2.5 parts of acetylsalicylic acid, 1.1 parts of solanine, 0.012 parts of metronidazole, blood root 0.4 parts of alkali, 1 part of chelerythrine, 1.2 parts of forsythol, 0.5 parts of hyperoside, 0.3 parts of isorhamnetin, 1 part of houttuyniatin, 0.7 parts of untethered terpene, 0.2 parts of kaempferol , 0.2 parts of resveratrol.
[0026] The preparation method of the pharmaceutical composition for ultrasonic interventional treatment of pelvic abscess is as follows:
[0027] (1) Take artificial bezoar, acetylsalicylic acid, solanine, metronidazole, sanguinarine, chelerythrine, forsythol, hyperin, isorhamnetin of said weight portion , houttuyniatin, untethered terpene, kaempferol, resveratrol, spare;
[0028] (2) the acetylsalicylic acid, metronidazole, sanguinarine, chelerythrine, forsythol, hyp...
Embodiment 3
[0032] The pharmaceutical composition for ultrasonic interventional treatment of pelvic abscess mainly consists of the following components by weight: 5.5 parts of artificial bezoar, 3.5 parts of acetylsalicylic acid, 1.25 parts of solanine, 0.02 parts of metronidazole, blood root 0.7 parts of alkali, 1.25 parts of chelerythrine, 1.9 parts of forsythol, 0.9 parts of hyperoside, 0.5 parts of isorhamnetin, 2.25 parts of houttuyonin, 0.8 parts of untethered terpene, 0.3 parts of kaempferol , 0.55 parts of resveratrol.
[0033] The preparation method of the pharmaceutical composition for ultrasonic interventional treatment of pelvic abscess is as follows:
[0034] (1) Take artificial bezoar, acetylsalicylic acid, solanine, metronidazole, sanguinarine, chelerythrine, forsythol, hyperin, isorhamnetin of said weight portion , houttuyniatin, untethered terpene, kaempferol, resveratrol, spare;
[0035](2) the acetylsalicylic acid, metronidazole, sanguinarine, chelerythrine, forsythol...
PUM
Property | Measurement | Unit |
---|---|---|
Aperture | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com